2 Best Pharma Stocks to Buy in May
Picking individual stocks in this chaotic market isn't for the faint of heart. The COVID-19 pandemic has clouded the corporate earnings landscape for at least the remainder of the year, and this murky forecast could easily spill over into 2021. What's more, a number of vital industries may end up receiving unprecedented levels of state aid before everything is said and done. The struggling airline industry, in fact, is already being propped up by governments around the world.
Are there any stocks worth buying in this exceedingly brutal market? Although there's no way to accurately predict when this rather surreal period in modern history will end, big pharma stocks AstraZeneca (NYSE: AZN) and Bristol Myers Squibb (NYSE: BMY) are two names that should be able to hold up even if this pandemic persists for another full year.
Here's why investors may want to buy these two big pharma stocks this month.
Source Fool.com
